Circulating Tumor Cells and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer

被引：0
|
作者：
Pleskow, H. [1 ]
Otani, K. [1 ]
Kusaka, E. [1 ]
Ukleja, J. [1 ]
Balza, R. [2 ]
Fisher, R. [1 ]
Broderick, K. [3 ]
Maheswaran, S. [3 ]
Haber, D. [3 ]
Saylor, P. J. [3 ]
Miyamoto, D. T. [1 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3222
引用
收藏
页码：E534 / E535
页数：2
相关论文
共 50 条
  • [21] Lymph Node Response in a Patient With Metastatic Castration-resistant Prostate Cancer Treated With Radium-223
    Poon, Darren M. C.
    Wong, Kenneth C. W.
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : E397 - E401
  • [22] The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer
    Sartor, Oliver
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 570 - 572
  • [23] Radium-223 therapy in Metastatic Castration-Resistant Prostate Cancer: effects on tumor and normal cell lines
    Balteiro, G.
    Marques, I.
    Abrantes, M.
    Neves, A.
    Meireles, I.
    Pires, A.
    Costa, G.
    Tavares-Silva, E.
    Figueiredo, A.
    Botelho, M.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29 : 30 - 30
  • [24] Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistant prostate cancer
    Vidal, M.
    Cardenas-Perilla, R.
    Delgado, A.
    Moron, S.
    Blair, J. L. Londono
    Vega, I.
    Ochoa, J. J. Correa
    Rojas, J.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (05): : 310 - 317
  • [25] Radium-223 Dichloride for Metastatic Castration-resistant Prostate Cancer: The Urologist's Perspective
    Shore, Neal D.
    [J]. UROLOGY, 2015, 85 (04) : 717 - 724
  • [26] EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
    Thorsten D. Poeppel
    Daria Handkiewicz-Junak
    Michael Andreeff
    Alexander Becherer
    Andreas Bockisch
    Eva Fricke
    Lilli Geworski
    Alexander Heinzel
    Bernd J. Krause
    Thomas Krause
    Markus Mitterhauser
    Wilfried Sonnenschein
    Lisa Bodei
    Roberto C. Delgado-Bolton
    Michael Gabriel
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 824 - 845
  • [27] Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
    Vidal, Monica
    Delgado, Alejandro
    Martinez, Carlos
    Jaime Correa, Jose
    Cristina Durango, Isabel
    [J]. INTERNATIONAL BRAZ J UROL, 2020, 46 (04): : 599 - 611
  • [28] Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223
    Rodriguez-Vida, A.
    Torregrosa, M. D.
    Pinto, A.
    Climent, M. A.
    Olmos, D.
    Carles, J.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 679 - 686
  • [29] EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
    Poeppel, Thorsten D.
    Handkiewicz-Junak, Daria
    Andreeff, Michael
    Becherer, Alexander
    Bockisch, Andreas
    Fricke, Eva
    Geworski, Lilli
    Heinzel, Alexander
    Krause, Bernd J.
    Krause, Thomas
    Mitterhauser, Markus
    Sonnenschein, Wilfried
    Bodei, Lisa
    Delgado-Bolton, Roberto C.
    Gabriel, Michael
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (05) : 824 - 845
  • [30] Predictors for Survival After Radium-223 Treatment for Castration-Resistant Metastatic Prostate Cancer
    Anderson, E.
    Wong, W. W.
    Mohammadi, H.
    Daniels, T. B.
    Vora, S.
    Schild, S. E.
    Keole, S. R.
    Choo, C. R.
    Tzou, K. S.
    Bryce, A.
    Ho, T. H.
    Quevedo, F. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E255 - E255
12345